Adagio Medical Holdings, Inc., a leading developer of catheter ablation technologies for cardiac arrhythmias, today announced preliminary acute safety and efficacy results from its FULCRUM-VT study, evaluating Ultralow Temperature Cryoablation (ULTC) for the treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)…
Joining world-changing breakthroughs such as YouTube, the Apple iPhone, IBM’s Watson, and the Large Hadron Collider, the Double Neural Bypass, a revolutionary brain-computer interface developed at Northwell Health’s Feinstein Institutes for Medical Research, has been inducted into TIME’s Best Inventions…
Satellos Bioscience Inc., a clinical-stage biotechnology company pioneering regenerative treatments for degenerative muscle diseases, has announced compelling new results supporting the safety, tolerability, and early signs of efficacy of its lead candidate, SAT-3247, in adults with Duchenne muscular dystrophy (DMD).…
Wysa, a global leader in AI-guided mental healthcare, has released compelling new research showing that loneliness is far more than an emotional or social issue—it is a serious clinical risk factor with deep implications for both mental and physical health.…
Genethon, a global leader in gene therapy research for rare genetic diseases, and Hansa Biopharma, a Sweden-based biotechnology company pioneering IgG-cleaving enzyme technology, have announced a major milestone in the field of gene therapy. A patient suffering from Crigler–Najjar syndrome,…
Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company and wholly owned subsidiary of Bayer AG, announced the publication of a pivotal study in Science describing a major advancement in cancer research — the discovery and preclinical validation of small-molecule covalent inhibitors…
Genethon, a global pioneer in gene therapy research and development for rare genetic diseases, has announced compelling long-term efficacy results from its micro-dystrophin gene therapy (GNT0004) for Duchenne muscular dystrophy (DMD). The data, presented at the 32nd Annual Congress of…
A new clinical study from Citruslabs, a leading independent research organization, has found that Droptics, an innovative eye drop designed specifically for the digital age, provides significant relief for people suffering from screen-induced eye strain, dryness, and fatigue. As modern…
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage biotechnology company focused on developing transformative gene therapies for rare neurological diseases, has announced a key regulatory update for its NGN-401 gene therapy in Rett syndrome. The company completed discussions with the U.S. Food…
The Institute of Clinical Research (The ICR) has announced the launch of its Company Membership Scheme, a strategic initiative aimed at strengthening professional development, collaboration, and engagement across the clinical research sector. The program is designed to broaden access to…